Flerie AB (publ) (STO:FLERIE)
Sweden · Delayed Price · Currency is SEK 35.60
-0.10 (-0.28%)
Feb 10, 2026, 5:29 PM CET
Flerie AB Market Cap
Flerie AB has a market cap or net worth of 2.77 billion as of February 10, 2026. Its market cap has decreased by -26.73% in one year.
Market Cap
2.77B
Enterprise Value
2.23B
Revenue
2.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.60
Market Cap Chart
Since June 11, 2024, Flerie AB's market cap has decreased from 4.11B to 2.77B, a decrease of -32.66%. That is a compound annual growth rate of -21.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 2.77B | -4.67% |
| Dec 30, 2025 | 2.90B | -20.86% |
| Dec 30, 2024 | 3.67B | -10.74% |
| Jun 11, 2024 | 4.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.79B |
| Saniona AB | 3.40B |
| Vicore Pharma Holding AB | 3.03B |
| Diamyd Medical AB | 2.37B |
| Egetis Therapeutics AB | 2.02B |
| BioInvent International AB | 1.73B |
| Genovis AB (publ.) | 1.35B |
| Cantargia AB | 1.26B |